Nuvation Bio Inc.
NUVB
$2.88
-$0.02-0.69%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -59.01M | -53.24M | -49.45M | -41.21M | -462.49M |
| Total Depreciation and Amortization | 356.00K | 310.00K | 219.00K | 162.00K | 244.00K |
| Total Amortization of Deferred Charges | 18.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.26M | 7.54M | 9.67M | 4.99M | 431.05M |
| Change in Net Operating Assets | 194.00K | 2.76M | -6.75M | 4.97M | -6.12M |
| Cash from Operations | -48.18M | -42.63M | -46.30M | -31.09M | -37.32M |
| Capital Expenditure | -181.00K | -72.00K | 13.00K | -148.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -92.00K | 0.00 | 12.52M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.06M | 54.25M | 51.85M | 29.26M | 21.75M |
| Cash from Investing | 54.88M | 54.18M | 51.77M | 29.12M | 34.27M |
| Total Debt Issued | 48.90M | -- | 5.57M | 0.00 | 7.04M |
| Total Debt Repaid | -166.00K | -534.00K | -7.63M | -3.21M | -6.32M |
| Issuance of Common Stock | 1.30M | 1.08M | 1.16M | 1.67M | 2.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 143.39M | -- | -- | -- | -- |
| Cash from Financing | 193.42M | 548.00K | -900.00K | -1.54M | 2.75M |
| Foreign Exchange rate Adjustments | -128.00K | 151.00K | 1.12M | -742.00K | 78.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 199.99M | 12.25M | 5.69M | -4.25M | -225.00K |